Hepatitis A susceptibility parallels high COVID-19 mortality
| Autor: | Fatma Burcu Belen, Kadir Mutlu Hayran, Faik Sarialioglu |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Coronavirus disease 2019 (COVID-19)
viruses 030204 cardiovascular system & hematology Article 03 medical and health sciences 0302 clinical medicine Risk Factors Immunity vaccine Humans Medicine Ships 0303 health sciences 030306 microbiology business.industry COVID-19 Hepatitis A General Medicine Middle Aged biochemical phenomena metabolism and nutrition medicine.disease mortality Virology Hepatitis a virus Disease Susceptibility Hepatitis A virus business |
| Zdroj: | Turkish Journal of Medical Sciences |
| ISSN: | 1303-6165 |
| Popis: | Background/aim COVID-19 has become the biggest health problem of this century. It has been hypothesized that immunity against hepatitis A virus (HAV) may provide protection from COVID- 19. Materials and methods As of 10June 2020, the infection had spread to 213 countries, with 7.3 million people infected and 413,733 dead. This data was combined with the World Health Organization susceptibility classification on the worldwide prevalence of HAV, and the relationship between HAV susceptibility and COVID-19 mortality were analyzed. Results When the data from 213 countries were analyzed, it was found that there was a significant increasing trend in COVID-19 mortality rates by HAV susceptibility (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|